Skip Navigation

European Heart Journal 1986 7(5):418-424;
Copyright © 1986 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by THIEMERMANN, C.
Right arrow Articles by SCHRÖR, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by THIEMERMANN, C.
Right arrow Articles by SCHRÖR, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1986 The European Society of Cardiology

Successful treatment of acute myocardial ischaemia with teopranitol—a novel organic nitrate*

C. THIEMERMANN, E. F. SMITH, III{dagger} and K. SCHRÖR

Pharmakologisches Institut der Universität Köln Gleueler Str. 24, D-5000 Köln 41, F.R.

Received 10 October 1985; revised 11 December 1985; .

Address for correspondence: Dr Karsten Schrör, Pharmakologisches Institut, Universität Köln, D-5000 Koln 41, F.R.G.

Abstract

The present study was designed to examine the effects of a new organic nitrate, teopranitol, in acute myocardial ischaemia. Adult cats were subjected to 5 h of myocardial ischaemia by permanent ligation of the left anterior descending coronary artery (LAD). Teopranitol (10 mg kg–1 x h) or physiological saline (vehicle) was infused i.v., beginning 30 min after LAD occlusion and continued until the end of the experiment. All animals subjected to myocardial ischaemia showed a significant elevation of the ST-segment within 20 min of LAD occlusion. In the LAD-vehicle group, the ST-segment elevation continued to increase; teopranitol attentuated this increase and significantly reduced the ST-segment elevation at 4 and 5 h (P<0.05). The loss of creatine phosphokinase-specific activity from the ischaemic myocardium was significantly reduced by teopranitol (P<0.05), indicating an improved preservation of myocardial tissue. There was a significant initial reduction in mean arterial blood pressure by teopranitol in sham-operated cats but no consistent change of this parameter, heart rate or the computed pressure-rate product in LAD-occluded cats. Teopranitol did completely reverse the ischaemia induced formation of platelet aggregates at 1 to 5 h (P<0.05). It is concluded that teopranitol exerts a significant protective effect in acute myocardial ischaemia in vivo that is independent of changes in systemic haemodynamics and might be associated with the generation of an antiplatelet activity in vivo.

Key Words: Teopranitol • organic nitrates • myocardial ischaemia • creatine phosphokinase activity • ST-segment • ECG • platelet aggregates


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.